MEDIA OUTREACH NEWSWIRE

Jacobson Pharmas Proposed Spin-off and Separate Listing of JBM Limited on The Main Board of The Stock Exchange of Hong Kong Limited

993
×

Jacobson Pharmas Proposed Spin-off and Separate Listing of JBM Limited on The Main Board of The Stock Exchange of Hong Kong Limited

Sebarkan artikel ini

Declaration of Conditional Special Interim Dividend

HONG KONG SAR – 15 January 2021 – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced the declaration of a conditional special interim dividend by way of a distribution in specie of an aggregate of 241,777,625 JBM Shares, representing approximately 27.1% of the total number of JBM Shares in issue immediately upon completion of the proposed spin-off, to the qualifying shareholders.

Baca Juga  DFI Retail Group Luncurkan Program Percontohan Pertanian Padi Rendah Kabon untuk Mengurangi Emisi Gas Rumah Kaca Setidaknya 30%

As of today, the total number of issued shares of the Company (“Shares”) is 1,934,221,000. Assuming there is no change in the total number of shares from today up to 29 January 2021 (the “Record Date”), the qualifying shareholders will receive one JBM Share for every eight Shares held on the Record Date.

Baca Juga  VinFast delivered 400 VF 3 to Indonesian dealers and customers within two months of launch
Baca Juga  Lee Kum Kee gives support to the 8th International Master Chef Charity Gala Dinner

The distribution is conditional on the public offer becoming unconditional in all respects. If such condition is not satisfied, the proposed spin-off will not take place and the distribution will not be made.